Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
Clinical trial NCT03181815 · UNKNOWN
Trial details
- NCT number
- NCT03181815
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.